Asia-Pacific Biotech News

AUSTRALIA – Potential of Anisina to become major new chemotherapy.

AUSTRALIA – Phylogica peptide fusion kills aggressive breast cancer cells.

INDIA – South Asia running out of groundwater.

JAPAN – Fruit fly studies shed light on adaptability.

KOREA – Hanmi Pharm begins phase 2 clinical trials on new long-acting human growth hormone drug.

MALAYSIA – Researchers discover breakthrough treatment for depression.

MALAYSIA – New diagnosis tool pushed to cope with diabetes in Asia.

SINGAPORE – Scientists discover gene that allows a peek into the future on eye disease.

SINGAPORE – Babies from moms with hepatitis have better immune systems.

THE PHILIPPINES – Debate persists on pneumonia vaccine in the Philippines.

VIETNAM – Second hookworm genome hoped to lead to vaccines.

AFRICA – Shop-based malaria kit boosts testing for disease.

BRAZIL – Prospective Chagas vaccine proves effective in trials.

EUROPE – Vaccine against placental malaria to start human tests in Germany and Benin.

SRI LANKA – Sri Lankan farmers told to adapt to changing climate.

UNITED STATES – Genetic markers play a role in who benefits from aspirin, NSAIDs to lower colon cancer risk.

UNITED STATES – Potential Ebola treatment mechanism discovered.

UNITED STATES – Researchers develop new potential drug for rare leukemia.

UNITED STATES – Researchers find new link between neurodegenerative diseases and abnormal immune responses.

NEWS – Lilly and Innovent Biologics enter strategic alliance; one of the largest biotech drug development collaborations in China.

NEWS – ZAI Lab enrolls first patient in Phase 1 study of ZL-2102.

NEWS – LamdaGen Corporation launches Taiwan diagnostic subsidiary.

NEWS – 3M makes a greater commitment in China's West Region; Plans for a new customer technical center.

NEWS – NCKU launches campus food ingredients registration platform.

NEWS – Lab-free immune therapy developed.

NEWS – Hainan Province, Hengda Health and Korean Yuanchen enter strategic cooperation agreement.

NEWS – Bristol-Myers Squibb and ZAI Lab enter licensing agreement to develop, manufacture and commercialize brivanib in China.

NEWS – Concord Medical acquires Fortis Surgical Hospital in Singapore.

NEWS – Merck Animal Health and China Animal Husbandry Industry Co., Ltd establish partnership.

NEWS – Helsinn Group signs exclusive agreement with Mundipharma for distribution and license of anamorelin in China, Hong Kong and Macau.

NEWS – C-FDA approves IND for D-Pharm's anti-epileptic drug, DP-VPA in China.

NEWS – Waters' UPLC I-Class/Xevo TQ-S System approved for in vitro diagnostic use in China.

NEWS – Vitruvias Therapeutics and Sunny Pharmtech form partnership to co-develop several high value generic drugs.

NEWS – Professor Xie Xiaoliang first Chinese Albany Award winner.

RESEARCH INSTITUTES – A look at Duke Kunshan University Global Health Research Center.

RESEARCH INSTITUTES – The NYU-ECNU Institute of Brain and Cognitive Science.

Reflections on a “Systems Approach” to Medicines in Health Systems.

The Case for Rarity.

Singapore's Approach to the Challenge of High-Cost Medical Interventions.

Universal Health Coverage and the Social Value of Drug Development.

Taking a Harder Look at Anesthesia.

Life Sciences in Asia: Is The Tiger An Endangered Species?

Bridging the Scientific Gap; a Conversation with Ada E. Yonath.

Biogen Idec's Aducanumab (BIIB037) shown to reduce brain amyloid plaque levels slow cognitive decline in patients with prodromal or mild Alzheimer's disease.

Johnson Matthey recognized in 2015 CMO Leaderships Awards.

Heraeus enters agreement to acquire NeoMetrics.

AstraZeneca and Daiichi Sankyo to jointly commercialize MOVANTIK in the US.

AbbVie and C2N enter worldwide license agreement for Alzheimer's disease therapy.

Menara Landmark Medical Suites expands healthcare and medical offerings in Johor Bahru.

Sigma-Aldrich® expands customer-centric model with investments in Singapore.

NTU setting up a new $30 million institute to boost Singapore's efforts in tackling human disease.